AJ Thurman, LA Potter, K Kim,
F Tassone… - Journal of …, 2020 - Springer
Background The purpose of this study was to conduct a 20-week controlled trial of lovastatin
(10 to 40 mg/day) in youth with fragile X syndrome (FXS) ages 10 to 17 years, combined with …